OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats
Meng Xiao He, Qingsheng Zhang, Chao Deng, et al.
Psychoneuroendocrinology (2014) Vol. 42, pp. 153-164
Closed Access | Times Cited: 81
Meng Xiao He, Qingsheng Zhang, Chao Deng, et al.
Psychoneuroendocrinology (2014) Vol. 42, pp. 153-164
Closed Access | Times Cited: 81
Showing 1-25 of 81 citing articles:
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management
Peter Manu, Lorena Dima, Matisyahu Shulman, et al.
Acta Psychiatrica Scandinavica (2015) Vol. 132, Iss. 2, pp. 97-108
Closed Access | Times Cited: 253
Peter Manu, Lorena Dima, Matisyahu Shulman, et al.
Acta Psychiatrica Scandinavica (2015) Vol. 132, Iss. 2, pp. 97-108
Closed Access | Times Cited: 253
Association Between Antipsychotic Medication Use and Diabetes
R. I. G. Holt
Current Diabetes Reports (2019) Vol. 19, Iss. 10
Open Access | Times Cited: 131
R. I. G. Holt
Current Diabetes Reports (2019) Vol. 19, Iss. 10
Open Access | Times Cited: 131
Schizophrenia: a disorder of broken brain bioenergetics
Nicholas Henkel, Xiajoun Wu, Sinead M. O’Donovan, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 5, pp. 2393-2404
Closed Access | Times Cited: 56
Nicholas Henkel, Xiajoun Wu, Sinead M. O’Donovan, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 5, pp. 2393-2404
Closed Access | Times Cited: 56
Diabetes and Mental Health
David J. Robinson, Kimberley Hanson, Akshay Jain, et al.
Canadian Journal of Diabetes (2023) Vol. 47, Iss. 4, pp. 308-344
Open Access | Times Cited: 36
David J. Robinson, Kimberley Hanson, Akshay Jain, et al.
Canadian Journal of Diabetes (2023) Vol. 47, Iss. 4, pp. 308-344
Open Access | Times Cited: 36
GLP-2 prevents antipsychotics-induced metabolic dysfunction in mice
Yanmin Peng, Chenzhang Feng, Shiyu Peng, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 1
Yanmin Peng, Chenzhang Feng, Shiyu Peng, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 1
Multi-Target Approach for Drug Discovery against Schizophrenia
Magda Kondej, Piotr Stępnicki, Agnieszka A. Kaczor
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3105-3105
Open Access | Times Cited: 79
Magda Kondej, Piotr Stępnicki, Agnieszka A. Kaczor
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3105-3105
Open Access | Times Cited: 79
Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes
Jiezhong Chen, Xu‐Feng Huang, Renfu Shao, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 77
Jiezhong Chen, Xu‐Feng Huang, Renfu Shao, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 77
Antipsychotics and glucose metabolism: how brain and body collide
Chantel Kowalchuk, L Castellani, Araba Chintoh, et al.
AJP Endocrinology and Metabolism (2018) Vol. 316, Iss. 1, pp. E1-E15
Open Access | Times Cited: 70
Chantel Kowalchuk, L Castellani, Araba Chintoh, et al.
AJP Endocrinology and Metabolism (2018) Vol. 316, Iss. 1, pp. E1-E15
Open Access | Times Cited: 70
Antipsychotics-induced metabolic alterations: Recounting the mechanistic insights, therapeutic targets and pharmacological alternatives
Raghunath Singh, Yashika Bansal, Bikash Medhi, et al.
European Journal of Pharmacology (2018) Vol. 844, pp. 231-240
Closed Access | Times Cited: 69
Raghunath Singh, Yashika Bansal, Bikash Medhi, et al.
European Journal of Pharmacology (2018) Vol. 844, pp. 231-240
Closed Access | Times Cited: 69
The histaminergic system as a target for the prevention of obesity and metabolic syndrome
Gustavo Provensi, Patrizio Blandina, Maria Beatrice Passani
Neuropharmacology (2015) Vol. 106, pp. 3-12
Closed Access | Times Cited: 68
Gustavo Provensi, Patrizio Blandina, Maria Beatrice Passani
Neuropharmacology (2015) Vol. 106, pp. 3-12
Closed Access | Times Cited: 68
Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
Jiamei Lian, Xu‐Feng Huang, Nagesh Pai, et al.
PLoS ONE (2014) Vol. 9, Iss. 8, pp. e104160-e104160
Open Access | Times Cited: 67
Jiamei Lian, Xu‐Feng Huang, Nagesh Pai, et al.
PLoS ONE (2014) Vol. 9, Iss. 8, pp. e104160-e104160
Open Access | Times Cited: 67
Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics
Simona Cernea, Lorena Dima, Christoph U. Correll, et al.
Drugs (2020) Vol. 80, Iss. 17, pp. 1763-1781
Closed Access | Times Cited: 54
Simona Cernea, Lorena Dima, Christoph U. Correll, et al.
Drugs (2020) Vol. 80, Iss. 17, pp. 1763-1781
Closed Access | Times Cited: 54
Understanding the Effects of Antipsychotics on Appetite Control
Sayani Mukherjee, Silje Skrede, Edward Milbank, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 35
Sayani Mukherjee, Silje Skrede, Edward Milbank, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 35
Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways
Jiamei Lian, Xu‐Feng Huang, Nagesh Pai, et al.
Psychoneuroendocrinology (2014) Vol. 48, pp. 77-86
Closed Access | Times Cited: 60
Jiamei Lian, Xu‐Feng Huang, Nagesh Pai, et al.
Psychoneuroendocrinology (2014) Vol. 48, pp. 77-86
Closed Access | Times Cited: 60
H1-histamine receptor affinity predicts weight gain with antidepressants
Virginio Salvi, Claudio Mencacci, Francesco Barone‐Adesi
European Neuropsychopharmacology (2016) Vol. 26, Iss. 10, pp. 1673-1677
Closed Access | Times Cited: 57
Virginio Salvi, Claudio Mencacci, Francesco Barone‐Adesi
European Neuropsychopharmacology (2016) Vol. 26, Iss. 10, pp. 1673-1677
Closed Access | Times Cited: 57
Estradiol effects on hypothalamic AMPK and BAT thermogenesis: A gateway for obesity treatment?
Miguel López, Manuel Tena‐Sempere
Pharmacology & Therapeutics (2017) Vol. 178, pp. 109-122
Open Access | Times Cited: 57
Miguel López, Manuel Tena‐Sempere
Pharmacology & Therapeutics (2017) Vol. 178, pp. 109-122
Open Access | Times Cited: 57
Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications
Jiamei Lian, Xu‐Feng Huang, Nagesh Pai, et al.
Pharmacological Research (2016) Vol. 106, pp. 51-63
Closed Access | Times Cited: 53
Jiamei Lian, Xu‐Feng Huang, Nagesh Pai, et al.
Pharmacological Research (2016) Vol. 106, pp. 51-63
Closed Access | Times Cited: 53
Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
Wade Marteene, Karl Winckel, Samantha Hollingworth, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 12, pp. 1149-1160
Open Access | Times Cited: 47
Wade Marteene, Karl Winckel, Samantha Hollingworth, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 12, pp. 1149-1160
Open Access | Times Cited: 47
Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells
Kazuki Okubo, Makoto Isono, Kosuke Miyai, et al.
Cancer Science (2019) Vol. 111, Iss. 1, pp. 112-126
Open Access | Times Cited: 47
Kazuki Okubo, Makoto Isono, Kosuke Miyai, et al.
Cancer Science (2019) Vol. 111, Iss. 1, pp. 112-126
Open Access | Times Cited: 47
Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking
Chiara Vantaggiato, Elena Panzeri, Andrea Citterio, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 3, pp. 189-210
Closed Access | Times Cited: 44
Chiara Vantaggiato, Elena Panzeri, Andrea Citterio, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 3, pp. 189-210
Closed Access | Times Cited: 44
Mechanism and treatments of antipsychotic-induced weight gain
Wujie Ye, Jingyu Xing, Zekai Yu, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 6, pp. 423-433
Closed Access | Times Cited: 16
Wujie Ye, Jingyu Xing, Zekai Yu, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 6, pp. 423-433
Closed Access | Times Cited: 16
Olanzapine, risperidone and ziprasidone differently affect lysosomal function and autophagy, reflecting their different metabolic risk in patients
Marco Pozzi, Chiara Vantaggiato, F Brivio, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Marco Pozzi, Chiara Vantaggiato, F Brivio, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy
Donghong Cui, Yanmin Peng, Chengfang Zhang, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 11, pp. 4997-5007
Open Access | Times Cited: 40
Donghong Cui, Yanmin Peng, Chengfang Zhang, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 11, pp. 4997-5007
Open Access | Times Cited: 40
Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons
Chantel Kowalchuk, Pruntha Kanagasundaram, Denise D. Belsham, et al.
Psychoneuroendocrinology (2019) Vol. 104, pp. 42-48
Closed Access | Times Cited: 38
Chantel Kowalchuk, Pruntha Kanagasundaram, Denise D. Belsham, et al.
Psychoneuroendocrinology (2019) Vol. 104, pp. 42-48
Closed Access | Times Cited: 38
Effect of alpha-mangostin on olanzapine-induced metabolic disorders in rats.
Alireza Ardakanian, Mahboobeh Ghasemzadeh Rahbardar, Farzaneh Omidkhoda, et al.
PubMed (2022) Vol. 25, Iss. 2, pp. 198-207
Closed Access | Times Cited: 20
Alireza Ardakanian, Mahboobeh Ghasemzadeh Rahbardar, Farzaneh Omidkhoda, et al.
PubMed (2022) Vol. 25, Iss. 2, pp. 198-207
Closed Access | Times Cited: 20
